Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase™ platform gene editors to build a pipeline of treatments for serious genetic diseases. TORONTO, ON – Specific Biologics… Read More
Canada has a strong track record of medical innovation: insulin, stem-cell therapies and HIV drug cocktails all have their origins in this country. However, life-saving innovation has been limited in… Read More
VANCOUVER, BC & SHANGHAI- Virogin Biotech is pleased to announce the closing of its Series D2 round of financing, raising $127 million USD. The financing round was led by China… Read More
VANCOUVER, BC – Variational AI, developer of state-of-the-art generative AI technology to redefine the economics of drug development by accelerating the discovery of novel and optimized small molecule therapeutics, today announced… Read More
Approval backed by two Phase 3 clinical studies where RINVOQ (15 mg, once daily) showed efficacy across multiple measures of disease activity in active psoriatic arthritis (PsA) with a safety… Read More
